PDK1 and prostate adenocarcinoma: Of the four PDK isoforms (PDHK1-4), PDHK1 is the most frequently studied in the context of tumorigenesis and has previously been shown to be a direct target of AKT2 in prostate adenocarcinoma cells [42].